Funders › NY › The Barth Syndrome Foundation › 2020
Grants paid by The Barth Syndrome Foundation, tax year 2020
EIN 22-3755704 · Larchmont, NY · Form 990, Schedule I · NTEE T30
In tax year 2020, The Barth Syndrome Foundation (EIN 22-3755704) reported 5 grants paid totaling $201,587. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2020
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2020 | Boston Children's Hospital Boston, MA | U | $55,000 | paid | ESSENTIAL ACTIVITIES OF TAFAZZIN THAT ARE INDEPENDENT OF CARDIOLIPIN REMODELING | 202122249349300702 |
| 2020 | Stony Brook University Stony Brook, NY | U | $50,000 | paid | STRUCTURAL AND BIOPHYSICAL STUDIES OF TAFAZZIN | 202122249349300702 |
| 2020 | Texas A&m College Station, TX | B | $50,000 | paid | CARDIOLIPIN REQUIREMENT FOR MITOCHONDRIAL CALCIUM IMPORT | 202122249349300702 |
| 2020 | University of Connecticut Storrs, CT | B | $50,000 | paid | DEVELOPMENT OF MITOCHONDRIA-TARGETED PEPTIDE COMPOUNDS AS BARTH SYNDROME THERAPEUTICS | 202122249349300702 |
| 2020 | Duke University Durham, NC | B | -$3,413 | paid | REFUND RECEIVED OF PRIOR YEAR GRANT | 202122249349300702 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.